- Home
- ANIP vs ALIT Comparison
ANIP vs ALIT Comparison
Compare ANIP & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- ALIT
- Stock Information
- Founded
- ANIP 2001
- ALIT 2017
- Country
- ANIP United States
- ALIT United States
- Employees
- ANIP 897
- ALIT N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- ALIT Business Services
- Sector
- ANIP Health Care
- ALIT Consumer Discretionary
- Exchange
- ANIP Nasdaq
- ALIT Nasdaq
- Market Cap
- ANIP 2.0B
- ALIT 1.7B
- IPO Year
- ANIP N/A
- ALIT N/A
- Fundamental
- Price
- ANIP $90.60
- ALIT $2.88
- Analyst Decision
- ANIP Strong Buy
- ALIT Strong Buy
- Analyst Count
- ANIP 7
- ALIT 6
- Target Price
- ANIP $99.14
- ALIT $8.75
- AVG Volume (30 Days)
- ANIP 326.9K
- ALIT 7.5M
- Earning Date
- ANIP 11-07-2025
- ALIT 11-05-2025
- Dividend Yield
- ANIP N/A
- ALIT 5.56%
- EPS Growth
- ANIP N/A
- ALIT N/A
- EPS
- ANIP N/A
- ALIT N/A
- Revenue
- ANIP $747,399,000.00
- ALIT $2,311,000,000.00
- Revenue This Year
- ANIP $39.99
- ALIT $0.51
- Revenue Next Year
- ANIP $9.57
- ALIT $2.39
- P/E Ratio
- ANIP N/A
- ALIT N/A
- Revenue Growth
- ANIP 38.68
- ALIT N/A
- 52 Week Low
- ANIP $52.50
- ALIT $2.77
- 52 Week High
- ANIP $99.50
- ALIT $8.93
- Technical
- Relative Strength Index (RSI)
- ANIP 43.34
- ALIT 34.60
- Support Level
- ANIP $90.06
- ALIT $2.91
- Resistance Level
- ANIP $93.80
- ALIT $3.20
- Average True Range (ATR)
- ANIP 2.85
- ALIT 0.11
- MACD
- ANIP -0.23
- ALIT 0.01
- Stochastic Oscillator
- ANIP 31.95
- ALIT 26.44
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About ALIT Alight Inc.
Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.